These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16623)

  • 1. [Psychic drugs: predicting therapeutic effects and doses by test models with normal subjects (author's transl)].
    Taeuber K
    Arzneimittelforschung; 1977 Feb; 27(2A):319-24. PubMed ID: 16623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodological and theoretical aspects of the evaluation of psychotropic drugs in normal healthy volunteers (author's transl)].
    Debus G
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):109-18. PubMed ID: 360235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [General methodological problems of psychotropic drug trials (author's transl)].
    Heimann H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):119-29. PubMed ID: 360236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Planning of psychotropic drug trials. Statistical evaluation. Hypotheses and methods].
    Immich H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):185-92. PubMed ID: 30098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacopsychologic studies on normal subjects for the prediction of the therapeutic efficiency of psychotropic drugs].
    Janke W; Debus G
    Arzneimittelforschung; 1975 Jul; 25(7a):1185-94. PubMed ID: 1242347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difficulties of a clinician in planning psychopharmacological trials (author's transl)].
    Woggon B
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):140-6. PubMed ID: 360238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Taxonomy and assessment of psychological investigation methods in psychotropic drug trials (author's transl)].
    Baumann U; Seidenstücker G
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):165-75. PubMed ID: 360241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacopsychology].
    Fava GA; Staccini L; Delle Chiaie R; Belaise C; Tomba E
    Riv Psichiatr; 2014; 49(5):251-4. PubMed ID: 25424339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On predicting therapeutic usefulness of psychotropic drugs from experiments in health persons.
    Spiegel R
    Rev Pure Appl Pharmacol Sci; 1980; 1(3):215-91. PubMed ID: 7025115
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ethical and legal problems in first clinical trials of psychotropic drugs (author's transl)].
    Helmchen H
    Arzneimittelforschung; 1978; 28(8):1253-6. PubMed ID: 380572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and pattern-valence of psychoergic drug / A new method of comparing drugs applied to identical patients in randomized order (author's transl)].
    Lienert GA; Wall KD
    Arzneimittelforschung; 1980; 30(8):1302-6. PubMed ID: 7192147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proceedings: Clinical trials: Methodology versus practice? - An attempted Compromise (author's transl)].
    Abt K; Baumann U; Debus G; Ferner U; Heimann H; Müller-Oerlinghausen B; Woggon B
    Arzneimittelforschung; 1976; 26(6):1025-6. PubMed ID: 786306
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of psychotropic drugs in general somatic practice].
    Smulevich AB; Gindikin VIa; Avedisova AS; Vorontsova EA; Gertsik LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):594-9. PubMed ID: 4002952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidimensional pharmacopsychiatry in gerontopsychiatry: studies on the therapy with tricyclic antidepressant drugs (author's transl)].
    Bergener M; Hesse C; Hummel F; Husser J; Kern U
    Aktuelle Gerontol; 1976 Jul; 6(7):357-64. PubMed ID: 14541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statistical aspects in planning psychotropic drug trials (author's transl)].
    Ferner U
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):132-9. PubMed ID: 360237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of the clinical evaluation of psychotropic drugs].
    Moizeszowicz J
    Acta Psiquiatr Psicol Am Lat; 1975 Mar; 21(1):41-51. PubMed ID: 1163268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various current problems in clinical psychopharmacology].
    Smulevich AB; Panteleeva GP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(9):1345-51. PubMed ID: 6637291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.